Real-World Assessment of the Impact of Erectile Dysfunction on Sexual Planning Behavior and Health- and Treatment-Related Outcomes Among Men in 8 Countries

被引:4
|
作者
Goldstein, Irwin [1 ]
Giraldi, Annamaria [2 ]
Maculaitis, Martine C. [3 ]
Li, Vicky W. [3 ]
Hartzell-Cushanick, Rose [4 ]
Hassan, Tarek A. [5 ]
机构
[1] Alvarado Hosp, Sexual Med, 5555 Reservoir Dr 300, San Diego, CA 92120 USA
[2] Univ Copenhagen, Psychiat Ctr Copenhagen, Dept Clin Med, Sexol Clin, Copenhagen, Denmark
[3] Kantar, New York, NY USA
[4] San Diego Sexual Med, San Diego, CA USA
[5] Pfizer Inc, Med Affairs, New York, NY USA
来源
SEXUAL MEDICINE | 2020年 / 8卷 / 03期
关键词
Erectile Dysfunction; Phosphodiesterase; 5; Inhibitors; Sexual Activity Planning; Quality of Life; Global Male Sexual Habits Survey; 4TH INTERNATIONAL CONSULTATION; CONSENSUS STATEMENT; RISK-FACTORS; LIFE EVENTS; PREVALENCE; SILDENAFIL; SATISFACTION; INTERCOURSE; VALIDATION; ATTITUDES;
D O I
10.1016/j.esxm.2020.05.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The effect of erectile dysfunction (ED) on sexual planning behaviors and outcomes in men taking phosphodiesterase type 5 inhibitors (PDE5Is) is not well studied. Aims: To assess sexual habits, behaviors, and treatment-related outcomes of PDE5I-treated men with ED. Methods: This cross-sectional observational study recruited men aged 30 to 70 years with mild-to-severe ED from 8 diverse countries (the United States, the United Kingdom, Italy, Russia, Turkey, Israel, China, and Japan) to complete an approximately 15-minute survey. Differences were evaluated using bivariate analyses, and data were summarized using descriptive statistics. Main Outcome Measures: Self-reported data were collected for demographics, health characteristics, treat-ment, sexual habits, ED severity, ED-specific quality of life, and treatment satisfaction. Results: The survey was completed by 1,575 men. Mean frequency of sexual intercourse was 5.7 times/month. Overall, 87.1% of men always, often, or sometimes planned for sexual activity. Of those planning in advance, 32.8% and 40.6% agreed or strongly agreed that they plan for specific days of the week and times of day, respectively. Sexual planning habits were similar for patients taking short-acting vs long-acting PDE5Is. The most commonly cited reasons for planning sexual activity were needing time to take medication (48.4%), needing to make sure medication has taken effect (43.4%), convenient time for sexual activity (34.9%), and needing the partner's agreement (33.4%). Mean Self-Esteem and Relationship Questionnaire total score was 56.4. Conclusions: The differences in ED burden and sexual planning behavior observed across countries were not influenced by the type of PDE5I being taken, suggesting that cultural differences are an important factor when considering types of ED treatment. These findings provide a better understanding of burden, sexual habits, planning behaviors, quality of life, and treatment-related outcomes among PDE5I-treated men with ED in 8 Western and non -Western countries and may aid healthcare providers in selecting optimal treatments. Goldstein I, Giraldi A, Mac-ulaitis MC, Real-World Assessment of the Impact of Erectile Dysfunction on Sexual Planning Behavior and Health-and Treatment-Related Outcomes Among Men in 8 Countries. J Sex Med 2020;8:338-349. Copyright (c) 2020, The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:338 / 349
页数:12
相关论文
共 9 条
  • [1] REAL-WORLD ASSESSMENT OF THE IMPACT OF ERECTILE DYSFUNCTION ON SEXUAL PLANNING BEHAVIOR AND HEALTH- AND TREATMENT-RELATED OUTCOMES AMONG MEN IN 8 COUNTRIES
    Goldstein, I
    Giraldi, A.
    Maculaitis, M.
    Li, V
    Hartzell-Cushanick, R.
    Hassan, T.
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (01): : S34 - S34
  • [2] Management of patients with Dravet syndrome in real-world clinical practice across five countries in Europe: Impact of treatment-related burden on health outcomes
    Ross, E.
    Shah, D.
    Biedermann, P.
    Taylor, Y.
    Villanueva, V.
    Benitez, A.
    Berthoz, F. Truong
    Lai, S.
    Andrews, J. S.
    EPILEPSIA, 2024, 65 : 169 - 169
  • [3] Four years of real-world sexual function outcomes after Rezum therapy in men with and without baseline erectile dysfunction
    Hawks-Ladds, Noah
    Cook, Ryan
    Babar, Mustufa
    Zhu, Michael
    Schulz, Alison
    Loloi, Justin
    Masoud, Zaki
    Singh, Jaskirat
    Jamil, Hasan
    Sayed, Rahman
    Ines, Matthew
    Ciatto, Michael
    JOURNAL OF SEXUAL MEDICINE, 2024, 21 (09): : 777 - 786
  • [4] A real-world longitudinal assessment of the treatment-related symptoms and associated burden among patients receiving chemotherapy
    Trask, Peter
    Rusli, Emelly
    Holt, Tracy
    Kramer, Mordecai
    Galaznik, Aaron
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] A real-world assessment of the treatment-related symptoms and associated burden among patients with lung cancer receiving chemotherapy
    Galaznik, Aaron
    Rusli, Emelly
    Holt, Tracy
    Kramer, Mordecai
    Trask, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Real-world assessment of treatment-related symptoms and associated burden among African American and Caucasian patients receiving chemotherapy in the US
    Galaznik, Aaron
    Rusli, Emelly
    Holt, Tracy
    Kramer, Mordecai
    Trask, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Real-world assessment of the impact of “OFF” episodes on health-related quality of life among patients with Parkinson’s disease in the United States
    Andrew Thach
    Eddie Jones
    Eric Pappert
    James Pike
    Jack Wright
    Alexander Gillespie
    BMC Neurology, 21
  • [8] Real-world assessment of the impact of "OFF" episodes on health-related quality of life among patients with Parkinson's disease in the United States
    Thach, Andrew
    Jones, Eddie
    Pappert, Eric
    Pike, James
    Wright, Jack
    Gillespie, Alexander
    BMC NEUROLOGY, 2021, 21 (01)
  • [9] A real-world study on the clinicopathological profile, treatment outcomes and health-related quality of life, anxiety and depression among patients with desmoid tumor at two tertiary care centers in India
    Tansir, Ghazal
    Sharma, Aparna
    Biswas, Bivas
    Sah, Suryadev Narayan
    Roy, Somnath
    Deo, S. V. S.
    Agarwala, Sandeep
    Khan, Shah Alam
    Bakhshi, Sameer
    Pushpam, Deepam
    FRONTIERS IN ONCOLOGY, 2024, 14